Literature DB >> 31488422

Posttraumatic Stress Disorder Is Associated with Increased Risk of Ovarian Cancer: A Prospective and Retrospective Longitudinal Cohort Study.

Laura D Kubzansky1, Shelley S Tworoger1,2, Andrea L Roberts3, Tianyi Huang1,4, Karestan C Koenen1, Yongjoo Kim1.   

Abstract

Ovarian cancer is the deadliest gynecologic cancer. Chronic stress accelerates tumor growth in animal models of ovarian cancer. We therefore postulated that posttraumatic stress disorder (PTSD) may be associated with increased risk of ovarian cancer. We used data from the Nurses' Health Study II, a longitudinal cohort study with 26 years of follow-up, conducted from 1989 to 2015 with 54,710 subjects. Lifetime PTSD symptoms were measured in 2008. Self-reported ovarian cancer was validated with medical records. Risk of ovarian cancer was estimated with Cox proportional hazards models and further adjusted for known ovarian cancer risk factors (e.g., hormonal factors) and health risk factors (e.g., smoking). Fully prospective secondary analyses examined incident ovarian cancer occurring after PTSD assessment in 2008. In addition, we examined associations by menopausal status. During follow-up, 110 ovarian cancers were identified. Women with high PTSD symptoms had 2-fold greater risk of ovarian cancer versus women with no trauma exposure [age-adjusted HR = 2.10; 95% confidence interval (CI), 1.12-3.95]. Adjustment for health and ovarian cancer risk factors moderately attenuated this association (HR = 1.86; 95% CI, 0.98-3.51). Associations were similar or moderately stronger in fully prospective analyses (age-adjusted HR = 2.38; 95% CI, 0.98-5.76, N cases = 50) and in premenopausal women (HR = 3.42; 95% CI, 1.08-10.85). In conclusion, we show that PTSD symptoms are associated with increased risk of ovarian cancer. Better understanding of the underlying molecular mechanisms could lead to interventions that reduce ovarian cancer risk in women with PTSD and other stress-related mental disorders. SIGNIFICANCE: PTSD is associated with ovarian cancer risk, particularly in premenopausal women. Understanding the underlying molecular mechanisms will aid in formulating ways to reduce ovarian cancer risk associated with chronic stress. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2019        PMID: 31488422      PMCID: PMC6774860          DOI: 10.1158/0008-5472.CAN-19-1222

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  44 in total

Review 1.  Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis.

Authors:  Catherine M Olsen; Adèle C Green; David C Whiteman; Shahram Sadeghi; Fariba Kolahdooz; Penelope M Webb
Journal:  Eur J Cancer       Date:  2007-01-12       Impact factor: 9.162

2.  Use of antidepressants and risk of epithelial ovarian cancer.

Authors:  Lina S Mørch; Christian Dehlendorff; Louise Baandrup; Søren Friis; Susanne K Kjaer
Journal:  Int J Cancer       Date:  2017-08-18       Impact factor: 7.396

3.  Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.

Authors:  S A Narod; P Sun; P Ghadirian; H Lynch; C Isaacs; J Garber; B Weber; B Karlan; D Fishman; B Rosen; N Tung; S L Neuhausen
Journal:  Lancet       Date:  2001-05-12       Impact factor: 79.321

4.  Stress hormone-mediated invasion of ovarian cancer cells.

Authors:  Anil K Sood; Robert Bhatty; Aparna A Kamat; Charles N Landen; Liz Han; Premal H Thaker; Yang Li; David M Gershenson; Susan Lutgendorf; Steven W Cole
Journal:  Clin Cancer Res       Date:  2006-01-15       Impact factor: 12.531

5.  Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci.

Authors:  Merlise A Clyde; Rachel Palmieri Weber; Edwin S Iversen; Elizabeth M Poole; Jennifer A Doherty; Marc T Goodman; Roberta B Ness; Harvey A Risch; Mary Anne Rossing; Kathryn L Terry; Nicolas Wentzensen; Alice S Whittemore; Hoda Anton-Culver; Elisa V Bandera; Andrew Berchuck; Michael E Carney; Daniel W Cramer; Julie M Cunningham; Kara L Cushing-Haugen; Robert P Edwards; Brooke L Fridley; Ellen L Goode; Galina Lurie; Valerie McGuire; Francesmary Modugno; Kirsten B Moysich; Sara H Olson; Celeste Leigh Pearce; Malcolm C Pike; Joseph H Rothstein; Thomas A Sellers; Weiva Sieh; Daniel Stram; Pamela J Thompson; Robert A Vierkant; Kristine G Wicklund; Anna H Wu; Argyrios Ziogas; Shelley S Tworoger; Joellen M Schildkraut
Journal:  Am J Epidemiol       Date:  2016-10-03       Impact factor: 4.897

6.  Biologic effects of dopamine on tumor vasculature in ovarian carcinoma.

Authors:  Myrthala Moreno-Smith; Sun Joo Lee; Chunhua Lu; Archana S Nagaraja; Guangan He; Rajesha Rupaimoole; Hee Dong Han; Nicholas B Jennings; Ju-Won Roh; Masato Nishimura; Yu Kang; Julie K Allen; Guillermo N Armaiz; Koji Matsuo; Mian M K Shahzad; Justin Bottsford-Miller; Robert R Langley; Steve W Cole; Susan K Lutgendorf; Zahid H Siddik; Anil K Sood
Journal:  Neoplasia       Date:  2013-05       Impact factor: 5.715

7.  Adrenergic Stimulation of DUSP1 Impairs Chemotherapy Response in Ovarian Cancer.

Authors:  Yu Kang; Archana S Nagaraja; Guillermo N Armaiz-Pena; Piotr L Dorniak; Wei Hu; Rajesha Rupaimoole; Tao Liu; Kshipra M Gharpure; Rebecca A Previs; Jean M Hansen; Cristian Rodriguez-Aguayo; Cristina Ivan; Prahlad Ram; Vasudha Sehgal; Gabriel Lopez-Berestein; Susan K Lutgendorf; Steven W Cole; Anil K Sood
Journal:  Clin Cancer Res       Date:  2015-11-18       Impact factor: 12.531

8.  Reproducibility and validity of a self-administered physical activity questionnaire.

Authors:  A M Wolf; D J Hunter; G A Colditz; J E Manson; M J Stampfer; K A Corsano; B Rosner; A Kriska; W C Willett
Journal:  Int J Epidemiol       Date:  1994-10       Impact factor: 7.196

9.  Early transcriptional response of human ovarian and fallopian tube surface epithelial cells to norepinephrine.

Authors:  Anxhela Gjyshi; Sweta Dash; Ling Cen; Chia-Ho Cheng; Chaomei Zhang; Sean J Yoder; Jamie K Teer; Guillermo N Armaiz-Pena; Alvaro N A Monteiro
Journal:  Sci Rep       Date:  2018-05-29       Impact factor: 4.379

10.  Sustained adrenergic signaling leads to increased metastasis in ovarian cancer via increased PGE2 synthesis.

Authors:  A S Nagaraja; P L Dorniak; N C Sadaoui; Y Kang; T Lin; G Armaiz-Pena; S Y Wu; R Rupaimoole; J K Allen; K M Gharpure; S Pradeep; B Zand; R A Previs; J M Hansen; C Ivan; C Rodriguez-Aguayo; P Yang; G Lopez-Berestein; S K Lutgendorf; S W Cole; A K Sood
Journal:  Oncogene       Date:  2015-08-10       Impact factor: 9.867

View more
  10 in total

1.  Association of Posttraumatic Stress Disorder With Accelerated Cognitive Decline in Middle-aged Women.

Authors:  Andrea L Roberts; Jiaxuan Liu; Rebecca B Lawn; Shaili C Jha; Jennifer A Sumner; Jae H Kang; Eric B Rimm; Francine Grodstein; Laura D Kubzansky; Lori B Chibnik; Karestan C Koenen
Journal:  JAMA Netw Open       Date:  2022-06-01

2.  Lifetime Trauma Exposure and Posttraumatic Stress Disorder Among African Americans and Black Caribbeans by Sex and Ethnicity.

Authors:  Sophia Maria Gran-Ruaz; Robert Joseph Taylor; Grace Jacob; Monnica T Williams
Journal:  Front Psychiatry       Date:  2022-06-21       Impact factor: 5.435

3.  The blood transcriptome prior to ovarian cancer diagnosis: A case-control study in the NOWAC postgenome cohort.

Authors:  Mie Jareid; Igor Snapkov; Marit Holden; Lill-Tove Rasmussen Busund; Eiliv Lund; Therese Haugdahl Nøst
Journal:  PLoS One       Date:  2021-08-27       Impact factor: 3.240

4.  Posttraumatic Stress Disorder and Likelihood of Hormone Therapy Use among Women in the Nurses' Health Study II: A 26-Year Prospective Analysis.

Authors:  Rebecca B Lawn; Kristen M Nishimi; Yongjoo Kim; Sun Jae Jung; Andrea L Roberts; Jennifer A Sumner; Rebecca C Thurston; Lori B Chibnik; Eric B Rimm; Andrew D Ratanatharathorn; Shaili C Jha; Karestan C Koenen; Shelley S Tworoger; Laura D Kubzansky
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-12-21       Impact factor: 4.254

Review 5.  Stress Hormones: Emerging Targets in Gynecological Cancers.

Authors:  Guoqiang Chen; Lei Qiu; Jinghai Gao; Jing Wang; Jianhong Dang; Lingling Li; Zhijun Jin; Xiaojun Liu
Journal:  Front Cell Dev Biol       Date:  2021-07-09

6.  Posttraumatic stress disorder and changes in diet quality over 20 years among US women.

Authors:  Yongjoo Kim; Andrea L Roberts; Eric B Rimm; Lori B Chibnik; Shelley S Tworoger; Kristen M Nishimi; Jennifer A Sumner; Karestan C Koenen; Laura D Kubzansky
Journal:  Psychol Med       Date:  2019-11-26       Impact factor: 10.592

Review 7.  Posttraumatic stress disorder: from gene discovery to disease biology.

Authors:  Renato Polimanti; Frank R Wendt
Journal:  Psychol Med       Date:  2021-02-15       Impact factor: 10.592

8.  Marital status impacts survival in patients with upper tract urothelial carcinoma: a population-based, propensity-matched study.

Authors:  Keyi Wang; Weipu Mao; Heng Shi; Guangchun Wang; Lei Yin; Jinbo Xie; Lap Hong Ian; Hui Zhang; Bo Peng
Journal:  Transl Androl Urol       Date:  2020-08

9.  Stress-related disorders and subsequent cancer risk and mortality: a population-based and sibling-controlled cohort study in Sweden.

Authors:  Fan Tian; Fang Fang; Qing Shen; Weimin Ye; Unnur A Valdimarsdóttir; Huan Song
Journal:  Eur J Epidemiol       Date:  2022-08-13       Impact factor: 12.434

Review 10.  The Role of Psychologic Stress in Cancer Initiation: Clinical Relevance and Potential Molecular Mechanisms.

Authors:  Marta Falcinelli; Premal H Thaker; Susan K Lutgendorf; Suzanne D Conzen; Renée L Flaherty; Melanie S Flint
Journal:  Cancer Res       Date:  2021-07-15       Impact factor: 12.701

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.